Login / Signup

Suppressing Halide Segregation via Pyridine-Derivative Isomers Enables Efficient 1.68 eV Bandgap Perovskite Solar Cells.

Liu YangZheng FangYongbin JinHuiping FengBingru DengLingfang ZhengPeng XuJingfu ChenXueling ChenYangying ZhouCongbo ShiWei GaoJinxin YangXipeng XuChengbo TianLi-Qiang XieZhanhua Wei
Published in: Advanced materials (Deerfield Beach, Fla.) (2024)
Light-induced phase segregation is one of the main issues restricting the efficiency and stability of wide-bandgap perovskite solar cells (WBG PSCs). Small organic molecules with abundant functional groups can passivate various defects, and therefore suppress the ionic migration channels for phase segregation. Herein, a series of pyridine-derivative isomers containing amino and carboxyl are applied to modify the perovskite surface. The amino, carboxyl, and N-terminal of pyridine in all of these molecules can interact with undercoordinated Pb 2+ through coordination bonds and suppress halide ions migration via hydrogen bonding. Among them, the 5-amino-3-pyridine carboxyl acid (APA-3) treated devices win the champion performance, enabling an efficiency of 22.35% (certified 22.17%) using the 1.68 eV perovskite, which represents one of the highest values for WBG-PSCs. This is believed to be due to the more symmetric spatial distribution of the three functional groups of APA-3, which provides a better passivation effect independent of the molecular arrangement orientation. Therefore, the APA-3 passivated perovskite shows the slightest halide segregation, the lowest defect density, and the least nonradiative recombination. Moreover, the APA-3 passivated device retains 90% of the initial efficiency after 985 h of operation at the maximum power point, representing the robust durability of WBG-PSCs under working conditions.
Keyphrases
  • perovskite solar cells
  • room temperature
  • solar cells
  • high efficiency
  • water soluble
  • dna damage
  • heavy metals
  • signaling pathway
  • ionic liquid
  • quantum dots
  • oxidative stress
  • risk assessment
  • newly diagnosed